Does the alpha fetoprotein of liver cancer rise necessarily

Liver cancer patients with alpha-fetoprotein (AFP) levels may not be elevated, the diagnosis of liver cancer requires a combination of a variety of test methods and clinical data. Liver cancer patients with alpha-fetoprotein (AFP) levels may not be elevated. Alpha-fetoprotein is a commonly used liver cancer markers, but in some cases, its levels may be normal or not significantly elevated. Here are some conditions that may cause normal or insignificant increases in AFP levels: 1. Small liver cancer: When the liver cancer is small in size, it may not cause significant increases in AFP. 2. Special types of liver cancer: For example, fibrolamellar liver cancer, AFP levels are usually low or normal. 3. Other diseases: Some liver diseases, such as hepatitis and cirrhosis, may also cause mild increases in AFP. 4. Detection methods: The accuracy of AFP detection may be affected by factors such as detection method, time and sample quality. 5. Individual differences: AFP levels may vary from person to person, and may be high or low even if there is no liver cancer. Therefore, for patients suspected of liver cancer, AFP level is only a reference indicator, which needs to be comprehensively judged in combination with other examinations, such as liver ultrasound, CT, magnetic resonance imaging (MRI), etc., as well as the patient's clinical symptoms and medical history, etc. If the AFP level is elevated, further imaging examination or liver biopsy is required to confirm the diagnosis. For high-risk groups of liver cancer, such as hepatitis B, hepatitis C patients, long-term alcoholics, patients with liver cirrhosis, should be regularly screened for liver cancer, including AFP testing and liver ultrasound. If you find elevated AFP or suspicious liver lesions, should seek medical attention in time for early diagnosis and treatment. In short, AFP levels in patients with liver cancer is not necessarily elevated, the diagnosis of liver cancer requires a comprehensive variety of examination methods and clinical data. High-risk groups should be screened regularly for liver cancer in order to detect, diagnose and treat liver cancer early and improve the cure rate and survival rate of liver cancer. If there is doubt about AFP levels or the diagnosis of liver cancer, consult a doctor for more detailed and personalized advice.